<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Stem Cells Dev</journal-id>
<journal-id journal-id-type="iso-abbrev">Stem Cells Dev</journal-id>
<journal-id journal-id-type="publisher-id">scd</journal-id>
<journal-title-group>
<journal-title>Stem Cells and Development</journal-title>
</journal-title-group>
<issn pub-type="ppub">1547-3287</issn>
<issn pub-type="epub">1557-8534</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc.</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26393806</article-id>
<article-id pub-id-type="pmc">4599386</article-id>
<article-id pub-id-type="publisher-id">10.1089/scd.2015.0220</article-id>
<article-id pub-id-type="doi">10.1089/scd.2015.0220</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Mechanisms Regulating Impaired Neurogenesis of Fragile X Syndrome Human Embryonic Stem Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Telias</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2,</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mayshar</surname>
<given-names>Yoav</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amit</surname>
<given-names>Ami</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ben-Yosef</surname>
<given-names>Dalit</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>The Wolfe PGD-SC Lab, Racine IVF Unit, Lis Maternity Hospital, <institution>Tel Aviv Sourasky Medical Center</institution>, Tel Aviv, <country>Israel</country>.</aff>
<aff id="aff2"><label><sup>2</sup></label>Department of Cell and Developmental Biology Sackler Medical School, <institution>Tel Aviv University</institution>, Tel Aviv, <country>Israel</country>.</aff>
</contrib-group>
<author-notes>
<fn fn-type="current-aff" id="fn1">
<label>
<sup>*</sup>
</label>
<p>Current affiliation: Department of Molecular and Cell Biology, University of California, Berkeley, California.</p>
</fn>
<corresp>
<addr-line>Address correspondence to:</addr-line>
<addr-line>
<italic>Prof. Dalit Ben-Yosef</italic>
</addr-line>
<addr-line>
<italic>The Wolfe PGD-SC Lab</italic>
</addr-line>
<addr-line>
<italic>Racine IVF Unit</italic>
</addr-line>
<addr-line>
<italic>Lis Maternity Hospital</italic>
</addr-line>
<institution>
<italic>Tel Aviv Sourasky Medical Center</italic>
</institution>
<addr-line>
<italic>6 Weizmann Street</italic>
</addr-line>
<addr-line>
<italic>Tel Aviv 64239</italic>
</addr-line>
<country>Israel</country>
<break></break>
<italic>E-mail:</italic>
<email xlink:href="mailto:dalitb@tlvmc.gov.il">dalitb@tlvmc.gov.il</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>10</month>
<year>2015</year>
<!--string-date: October 15, 2015-->
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>9</month>
<year>2015</year>
<!--string-date: Prepublished on Liebert Instant Online September 22, 2015-->
</pub-date>
<volume>24</volume>
<issue>20</issue>
<fpage>2353</fpage>
<lpage>2365</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>6</month>
<year>2015</year>
<!--string-date: Received for publication June 28, 2015-->
</date>
<date date-type="accepted">
<day>04</day>
<month>8</month>
<year>2015</year>
<!--string-date: Accepted after revision August 4, 2015-->
</date>
</history>
<permissions>
<copyright-statement>Copyright 2015, Mary Ann Liebert, Inc.</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="scd.2015.0220.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Fragile X syndrome (FXS) is the most common form of inherited cognitive impairment. It is caused by developmental inactivation of the <italic>FMR1</italic> gene and the absence of its encoded protein FMRP, which plays pivotal roles in brain development and function. In FXS embryos with full <italic>FMR1</italic> mutation, FMRP is expressed during early embryogenesis and is gradually downregulated at the third trimester of pregnancy. FX-human embryonic stem cells (FX-hESCs), derived from FX human blastocysts, demonstrate the same pattern of developmentally regulated <italic>FMR1</italic> inactivation when subjected to in vitro neural differentiation (IVND). In this study, we used this in vitro human platform to explore the molecular mechanisms downstream to FMRP in the context of early human embryonic neurogenesis. Our results show a novel role for the <italic>SOX</italic> superfamily of transcription factors, specifically for <italic>SOX2</italic> and <italic>SOX9</italic>, which could explain the reduced and delayed neurogenesis observed in FX cells. In addition, we assess in this study the “GSK3β theory of FXS” for the first time in a human-based model. We found no evidence for a pathological increase in GSK3β protein levels upon cellular loss of FMRP, in contrast to what was found in the brain of <italic>Fmr1</italic> knockout mice. Our study adds novel data on potential downstream targets of FMRP and highlights the importance of the FX-hESC IVND system.</p>
</abstract>
<counts>
<fig-count count="7"></fig-count>
<ref-count count="66"></ref-count>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>